Insider Trading March 5, 2026

Columbia Banking SVP Disposes of $127,932 in Shares Under Prearranged Plan

Senior executive Torran B. Nixon sold 4,481 COLB shares across two days as analysts lift price targets amid mixed guidance and dividend continuation

By Marcus Reed COLB
Columbia Banking SVP Disposes of $127,932 in Shares Under Prearranged Plan
COLB

Torran B. Nixon, Senior Executive Vice President at Columbia Banking System, INC. (NASDAQ: COLB), sold a total of 4,481 shares on March 3 and March 4, 2026, under a pre-established 10B5-1 trading plan. The transactions totaled $127,932. Columbia Banking trades near $28, carries a P/E of 12.13, and yields 5.29%, while several analysts raised price targets following quarterly results and strategic developments.

Key Points

  • SVP Torran B. Nixon sold 4,481 COLB shares on March 3-4, 2026 under a 10B5-1 plan, generating $127,932 in proceeds.
  • Columbia Banking trades near $28 with a P/E of 12.13 and a 5.29% dividend yield; InvestingPro flags the stock as appearing undervalued relative to a Fair Value estimate.
  • Multiple analysts raised price targets after quarterly results and strategic developments, while some maintained Neutral/Hold ratings citing mixed guidance and earnings commentary.

Transaction overview

Torran B. Nixon, serving as Senior Executive Vice President at Columbia Banking System, INC. (NASDAQ: COLB), executed sales of common stock on March 3 and March 4, 2026, according to a filed report with the Securities and Exchange Commission. Across the two trading days Nixon sold a combined 4,481 shares, generating total proceeds of $127,932.

On March 3, Nixon sold 2,241 shares at a per-share price of $28.25. The subsequent day, March 4, he sold an additional 2,240 shares at $28.85 per share. The sales were carried out under a pre-arranged 10B5-1 trading plan that Nixon put in place on November 25, 2025.


Post-transaction holdings

Following the dispositions, Nixon retains direct ownership of 98,229 shares of Columbia Banking System common stock. His related indirect holdings include 3,650 shares held through a family trust and 1,876 shares held in a 401(k) account, as disclosed in the filing.


Market positioning and valuation metrics

Columbia Banking shares are trading near $28, positioned close to their 52-week low of $19.61 and below the 52-week high of $32.70. According to InvestingPro analysis cited in the filing summary, the company appears undervalued at current market levels, with a Fair Value estimate that suggests potential upside from the present price.

Key valuation and shareholder metrics highlighted in the filing include a price-to-earnings ratio of 12.13 and a dividend yield of 5.29%. The company is noted to have sustained dividend payments for 30 consecutive years.


Dividend and corporate developments

Columbia Banking System announced a quarterly cash dividend of $0.37 per common share. That dividend is payable on March 16, 2026, to shareholders of record as of February 27, 2026, per the company’s announcement included in the filing materials.


Analyst reactions and guidance notes

Following the company’s quarterly results and strategic updates, several analysts adjusted price targets and commentary:

  • Stephens raised its price target to $37.00 from $35.00, noting Columbia Banking’s fourth-quarter operating earnings per share of $0.82, above Stephens’ estimate of $0.74 and the Street consensus of $0.72.
  • Raymond James increased its target to $34.00 from $31.00, citing the completion of the PPBI deal and expectations for accelerating earnings per share growth.
  • DA Davidson adjusted its target to $32.50 from $30.00, retained a Neutral rating, and pointed to improvements in net interest margin as well as a committed share buyback plan.
  • Jefferies raised its price target to $32.00 from $30.00 while keeping a Hold rating, describing the quarter as "decent" and noting mixed fiscal year 2026 guidance.

These analyst moves were described in the filing materials as reflecting a generally positive outlook driven by earnings performance and strategic initiatives.


Context on the sale plan

The sales by Nixon were executed under the 10B5-1 plan established on November 25, 2025. The filing indicates the plan was prearranged prior to the transactions reported on March 3 and March 4, 2026.


What investors and market watchers are seeing

The filing combines executive-level transaction detail with company metrics and analyst repositioning that together present a snapshot of recent insider activity and market sentiment. The reported sale proceeds, aggregate holdings after the trades, dividend timing, valuation ratios, and analyst target changes are all set out in the disclosures filed with the SEC and summarized above.

Readers should note the information presented here is limited to the details included in the transaction and corporate disclosures: the number of shares sold, sale prices and dates, the insider’s holdings after the sales, the existence of the 10B5-1 plan, summary valuation metrics, the announced dividend, and the analyst target changes and commentary as reported.

Risks

  • Stock is trading near its 52-week low, indicating recent downward pressure on the share price - this affects equity investors and the broader banking sector.
  • Jefferies noted mixed fiscal year 2026 guidance, introducing uncertainty about near-term earnings growth - this impacts investor expectations in financial services and regional banking.
  • The sales were executed under a pre-arranged 10B5-1 plan, meaning the transactions may not reflect a change in the insider’s view of the company; this is a structural consideration for interpreting insider activity across markets.

More from Insider Trading

Hercules Capital Director Adds $45,079 Worth of Shares, Boosting Stake to 19,560 Mar 6, 2026 ResMed Director Disposes $520K in Shares as Company Posts Modest Beat on EPS Mar 6, 2026 Healthcare Realty CFO Makes Modest Share Purchase as Q4 Results Exceed Estimates Mar 6, 2026 RENN Fund Co-Portfolio Manager Adds to Position With $584 Purchase Mar 5, 2026 Lattice Semiconductor SVP Executes $3.49M Stock Sale Under Prearranged 10b5-1 Plan Mar 5, 2026